Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

John Shively

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequence

Concepts & Ideas

Living Beings

Procedures

Disorders

Colonic Neoplasms

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
45
Williams, Lawrence
32
Raubitschek, Andrew
26
Wu, Anna
25
Wong, Jeffrey
25
Reeve, Joseph
19
Yazaki, Paul
19
Lee, Terry
12
Walsh, John
10
Yamauchi, Dave
10
Hefta, LJ
9
Liu, An
8
Keire, David
7
Odom-Maryon, TL
7
Olafsen, Tove
7
Li, Lin

Sign-in to see all Coauthors

Publications

TOP 3
Lobo Elizabeth O; Zhang Zhifang; Shively John E
Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner.
Gu Angel; Tsark Walter; Holmes Kathryn V; Shively John E
Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture.
Li Chunxia; Chen Charng-Jui; Shively John E
Mutational analysis of the cytoplasmic domain of CEACAM1-4L in humanized mammary glands reveals key residues involved in lumen formation: stimulation by Thr-457 and inhibition by Ser-461.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of John Shively (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lobo Elizabeth O; Zhang Zhifang; Shively John E
Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner.
Journal of leukocyte biology 2009;86(2):205-18.
2009: Gu Angel; Tsark Walter; Holmes Kathryn V; Shively John E
Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture.
Experimental cell research 2009;315(10):1668-82.
2009: Li Chunxia; Chen Charng-Jui; Shively John E
Mutational analysis of the cytoplasmic domain of CEACAM1-4L in humanized mammary glands reveals key residues involved in lumen formation: stimulation by Thr-457 and inhibition by Ser-461.
Experimental cell research 2009;315(7):1225-33.
2009: Dery Kenneth J; Gusti Veronica; Gaur Shikha; Shively John E; Yen Yun; Gaur Rajesh K
Alternative splicing as a therapeutic target for human diseases.
Methods in molecular biology (Clifton, N.J.) 2009;555():127-44.
2008: Ozeki Munetaka; Shively John E
Differential cell fates induced by all-trans retinoic acid-treated HL-60 human leukemia cells.
Journal of leukocyte biology 2008;84(3):769-79.
2008: Zhang Zhifang; Cherryholmes Gregory; Mao Allen; Marek Claudia; Longmate Jeffrey; Kalos Michael; Amand R Paul St; Shively John E
High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia.
Experimental biology and medicine (Maywood, N.J.) 2008;233(9):1171-80.
2008: Zhang Zhifang; Cherryholmes Gregory; Shively John E
Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin.
Journal of leukocyte biology 2008;84(3):780-8.
2008: Jin Lan; Li Yun; Chen Charng-Jui; Sherman Mark A; Le Keith; Shively John E
Direct interaction of tumor suppressor CEACAM1 with beta catenin: identification of key residues in the long cytoplasmic domain.
Experimental biology and medicine (Maywood, N.J.) 2008;233(7):849-59.
2008: Li Lin; Bading James; Yazaki Paul J; Ahuja Amitkumar H; Crow Desiree; Colcher David; Williams Lawrence E; Wong Jeffrey Y C; Raubitschek Andrew; Shively John E
A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.
Bioconjugate chemistry 2008;19(1):89-96.
2008: Gaur Shikha; Shively John E; Yen Yun; Gaur Rajesh K
Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.
Molecular cancer 2008;7():46.
2007: Yokoyama S; Chen C-J; Nguyen T; Shively J E
Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation.
Oncogene 2007;26(55):7637-46.
2007: Olafsen Tove; Gu Zhennan; Sherman Mark A; Leyton Jeffrey V; Witkosky Michael E; Shively John E; Raubitschek Andrew A; Morrison Sherie L; Wu Anna M; Reiter Robert E
Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(4):396-405.
2007: Shively John E
18F labeling for immuno-PET: where speed and contrast meet.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(2):170-2.
2007: Chen Charng-Jui; Kirshner Julia; Sherman Mark A; Hu Weidong; Nguyen Tung; Shively John E
Mutation analysis of the short cytoplasmic domain of the cell-cell adhesion molecule CEACAM1 identifies residues that orchestrate actin binding and lumen formation.
The Journal of biological chemistry 2007;282(8):5749-60.
2007: Kenanova Vania; Olafsen Tove; Williams Lawrence E; Ruel Nora H; Longmate Jeffrey; Yazaki Paul J; Shively John E; Colcher David; Raubitschek Andrew A; Wu Anna M
Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy.
Cancer research 2007;67(2):718-26.
2006: Reeve Joseph R; Rosenquist Grace L; Keire David A; Chew Peter; Nicholas Hugh B; Davis Michael T; Lee Terry D; Shively John E; Backus Robert C
Crucial role of position 40 for interactions of CCK-58 revealed by sequence of cat CCK-58.
Biochemical and biophysical research communications 2006;348(3):819-25.
2006: Wong Jeffrey Y C; Chu David Z; Williams Lawrence E; Liu An; Zhan Jiping; Yamauchi Dave M; Wilczynski Sharon; Wu Anna M; Yazaki Paul J; Shively John E; Leong Lucille; Raubitschek Andrew A
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
Cancer biotherapy & radiopharmaceuticals 2006;21(2):88-100.
2006: Reeve Joseph R; Liddle Rodger A; Shively John E; Lee Terry D; Keire David A; Chew Peter; Vigna Steven R
Sequence variation outside the "active" region of dog and rabbit cholecystokinin-58 results in bioactivity differences.
Pancreas 2006;32(3):306-13.
2006: Li Chunxia; Kato Mitsuo; Shiue Lily; Shively John E; Ares Manuel; Lin Ren-Jang
Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays.
Cancer research 2006;66(4):1990-9.
2006: Li Lin; Yazaki Paul J; Anderson Anne-Line; Crow Desiree; Colcher David; Wu Anna M; Williams Lawrence E; Wong Jeffrey Y C; Raubitschek Andrew; Shively John E
Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.
Bioconjugate chemistry 2006;17(1):68-76.
2005: Wang Tieli; Tamae Daniel; LeBon Thomas; Shively John E; Yen Yun; Li Jian Jian
The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells.
Cancer research 2005;65(22):10338-46.
2005: Crow Desiree M; Williams Lawrence; Colcher David; Wong Jeffrey Y C; Raubitschek Andrew; Shively John E
Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
Bioconjugate chemistry 2005;16(5):1117-25.
2005: Olafsen Tove; Kenanova Vania E; Sundaresan Gobalakrishnan; Anderson Anne-Line; Crow Desiree; Yazaki Paul J; Li Lin; Press Michael F; Gambhir Sanjiv S; Williams Lawrence E; Wong Jeffrey Y C; Raubitschek Andrew A; Shively John E; Wu Anna M
Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.
Cancer research 2005;65(13):5907-16.
2005: Wilczynski Sharon P; Chen Yuan-Yuan; Chen Wengang; Howell Stephen B; Shively John E; Alberts David S
Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Human pathology 2005;36(3):242-9.
2005: Kenanova Vania; Olafsen Tove; Crow Desiree M; Sundaresan Gobalakrishnan; Subbarayan Murugesan; Carter Nora H; Ikle David N; Yazaki Paul J; Chatziioannou Arion F; Gambhir Sanjiv S; Williams Lawrence E; Shively John E; Colcher David; Raubitschek Andrew A; Wu Anna M
Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.
Cancer research 2005;65(2):622-31.
2004: Shively John E
CEACAM1 and hyperplastic polyps: new links in the chain of events leading to colon cancer.
Oncogene 2004;23(58):9303-5.
2004: Wong Jeffrey Y C; Chu David Z; Williams Lawrence E; Yamauchi Dave M; Ikle David N; Kwok Cheuk S; Liu An; Wilczynski Sharon; Colcher David; Yazaki Paul J; Shively John E; Wu Anna M; Raubitschek Andrew A
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5014-21.
2004: Reeve Joseph R; Liddle Rodger A; McVey Douglas C; Vigna Steven R; Solomon Travis E; Keire David A; Rosenquist Grace; Shively John E; Lee Terry D; Chew Peter; Green Gary M; Coskun Tamer
Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.
American journal of physiology. Gastrointestinal and liver physiology 2004;287(2):G326-33.
2004: Yazaki Paul J; Sherman Mark A; Shively John E; Ikle David; Williams Lawrence E; Wong Jeffrey Y C; Colcher David; Wu Anna M; Raubitschek Andrew A
Humanization of the anti-CEA T84.66 antibody based on crystal structure data.
Protein engineering, design & selection : PEDS 2004;17(5):481-9.
2004: Schumann Detlef; Huang Jie; Clarke Patrick E; Kirshner Julia; Tsai Shih-wa; Schumaker Verne N; Shively John E
Characterization of recombinant soluble carcinoembryonic antigen cell adhesion molecule 1.
Biochemical and biophysical research communications 2004;318(1):227-33.
2004: Olafsen Tove; Tan Giselle J; Cheung Chia-Wei; Yazaki Paul J; Park Jinha M; Shively John E; Williams Lawrence E; Raubitschek Andrew A; Press Michael F; Wu Anna M
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting.
Protein engineering, design & selection : PEDS 2004;17(4):315-23.
2004: Kirshner Julia; Hardy John; Wilczynski Sharon; Shively John E
Cell-cell adhesion molecule CEACAM1 is expressed in normal breast and milk and associates with beta1 integrin in a 3D model of morphogenesis.
Journal of molecular histology 2004;35(3):287-99.
2004: Chen Charng-Jui; Shively John E
The cell-cell adhesion molecule carcinoembryonic antigen-related cellular adhesion molecule 1 inhibits IL-2 production and proliferation in human T cells by association with Src homology protein-1 and down-regulates IL-2 receptor.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(6):3544-52.
2004: Olafsen Tove; Cheung Chia-Wei; Yazaki Paul J; Li Lin; Sundaresan Gobalakrishnan; Gambhir Sanjiv S; Sherman Mark A; Williams Lawrence E; Shively John E; Raubitschek Andrew A; Wu Anna M
Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications.
Protein engineering, design & selection : PEDS 2004;17(1):21-7.
2004: Guo Guozheng; Wang Tieli; Gao Qian; Tamae Daniel; Wong Patty; Chen Tammy; Chen Wei-Chung; Shively John E; Wong Jeffery Y C; Li Jian Jian
Expression of ErbB2 enhances radiation-induced NF-kappaB activation.
Oncogene 2004;23(2):535-45.
2003: Wong Jeffrey Y C; Shibata Stephen; Williams Lawrence E; Kwok Cheuk S; Liu An; Chu David Z; Yamauchi Dave M; Wilczynski Sharon; Ikle David N; Wu Anna M; Yazaki Paul J; Shively John E; Doroshow James H; Raubitschek Andrew A
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5842-52.
2003: Sundaresan Gobalakrishnan; Yazaki Paul J; Shively John E; Finn Ronald D; Larson Steven M; Raubitschek Andrew A; Williams Lawrence E; Chatziioannou Arion F; Gambhir Sanjiv S; Wu Anna M
124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(12):1962-9.
2003: Kirshner Julia; Schumann Detlef; Shively John E
CEACAM1, a cell-cell adhesion molecule, directly associates with annexin II in a three-dimensional model of mammary morphogenesis.
The Journal of biological chemistry 2003;278(50):50338-45.
2003: Keire David A; Vincent Wu S; Diehl David L; Chew Peter; Ho Fang-Jen; Davis Michael T; Lee Terry D; Shively John E; Walsh John H; Reeve Joseph R
Rat progastrin processing yields peptides with altered potency at the CCK-B receptor.
Regulatory peptides 2003;113(1-3):115-24.
2003: Reeve Joseph R; Keire David A; Coskun Tamer; Green Gary M; Evans Chris; Ho F J; Lee Terry D; Davis Michael T; Shively John E; Solomon Travis E
Synthesis of biologically active canine CCK-58.
Regulatory peptides 2003;113(1-3):71-7.
2003: Carmichael Jennifer A; Power Barbara E; Garrett Thomas P J; Yazaki Paul J; Shively John E; Raubischek Andrew A; Wu Anna M; Hudson Peter J
The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility.
Journal of molecular biology 2003;326(2):341-51.
2003: Kirshner Julia; Chen Charng-Jui; Liu Pingfang; Huang Jie; Shively John E
CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(2):521-6.
2002: Reeve Joseph R; McVey Douglas C; Bunnett Nigel W; Solomon Travis E; Keire David A; Ho F J; Davis Michael T; Lee Terry D; Shively John E; Vigna Steven R
Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58.
Pancreas 2002;25(3):e50-5.
2002: Li Lin; Olafsen Tove; Anderson Anne-Line; Wu Anna; Raubitschek Andrew A; Shively John E
Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody.
Bioconjugate chemistry 2002;13(5):985-95.
2002: Graham Kenneth; Shively John E
Improved initial yields in C-terminal sequence analysis by thiohydantoin chemistry using purified diphenylphosphoryl isothiocyanate: NMR evidence for a reaction intermediate in the coupling reaction.
Analytical biochemistry 2002;307(2):202-11.
2002: Li Lin; Tsai Shih-Wa; Anderson Anne-Line; Keire David A; Raubitschek Andrew A; Shively John E
Vinyl sulfone bifunctional derivatives of DOTA allow sulfhydryl- or amino-directed coupling to antibodies. Conjugates retain immunoreactivity and have similar biodistributions.
Bioconjugate chemistry 2002;13(1):110-5.
2001: Schumann D; Chen C J; Kaplan B; Shively J E
Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin.
The Journal of biological chemistry 2001;276(50):47421-33.
2001: Keire D A; Jang Y H; Li L; Dasgupta S; Goddard W A; Shively J E
Chelators for radioimmunotherapy: I. NMR and ab initio calculation studies on 1,4,7,10-tetra(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO4Pr) and 1,4,7-tris(carboxymethyl)-10-(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO3A1Pr).
Inorganic chemistry 2001;40(17):4310-8.
2001: Yazaki P J; Shively L; Clark C; Cheung C W; Le W; Szpikowska B; Shively J E; Raubitschek A A; Wu A M
Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications.
Journal of immunological methods 2001;253(1-2):195-208.
2001: Williams L E; Beatty B G; Shively J E; Beatty J D
Accumulation of radiolabeled anti-CEA antibody (mT84.66) in the case of multiple LS174T tumors in a nude mouse model.
Cancer biotherapy & radiopharmaceuticals 2001;16(2):147-57.
2001: Lewis M R; Kao J Y; Anderson A L; Shively J E; Raubitschek A
An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA.
Bioconjugate chemistry 2001;12(2):320-4.
2001: Tsai S W; Li L; Williams L E; Anderson A L; Raubitschek A A; Shively J E
Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragments.
Bioconjugate chemistry 2001;12(2):264-70.
2001: Yazaki P J; Wu A M; Tsai S W; Williams L E; Ikler D N; Wong J Y; Shively J E; Raubitschek A A
Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
Bioconjugate chemistry 2001;12(2):220-8.
2001: Williams L E; Wu A M; Yazaki P J; Liu A; Raubitschek A A; Shively J E; Wong J Y
Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
Cancer biotherapy & radiopharmaceuticals 2001;16(1):25-35.
2000: Wong JYC; Chu D Z; Yamauchi D M; Williams L E; Liu A; Wilczynski S; Wu A M; Shively J E; Doroshow J H; Raubitschek A A
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):3855-63.
2000: Xu X; Clarke P; Szalai G; Shively J E; Williams L E; Shyr Y; Shi E; Primus F J
Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Cancer research 2000;60(16):4475-84.
2000: Wu A M; Yazaki P J; Tsai S w; Nguyen K; Anderson A L; McCarthy D W; Welch M J; Shively J E; Williams L E; Raubitschek A A; Wong J Y; Toyokuni T; Phelps M E; Gambhir S S
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(15):8495-500.
2000: Tsai S W; Sun Y; Williams L E; Raubitschek A A; Wu A M; Shively J E
Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5.
Bioconjugate chemistry 2000;11(3):327-34.
2000: Wong J Y; Wang J; Liu A; Odom-Maryon T; Shively J E; Raubitschek A A; Williams L E
Evaluating changes in stable chromosomal translocation frequency in patients receiving radioimmunotherapy.
International journal of radiation oncology, biology, physics 2000;46(3):599-607.
1999: Wong J Y; Somlo G; Odom-Maryon T; Williams L E; Liu A; Yamauchi D; Wu A M; Yazaki P; Wilczynski S; Shively J E; Forman S; Doroshow J H; Raubitschek A A
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3224s-3231s.
1999: Neumaier M; Gaida F J; Lewis M R; Hefta L J; Shively L E; Raubitschek A; Shively J E
A chimeric anti-CEA antibody with heavy interchain disulfide bonds deleted: molecular characterization and biodistributions in normal and tumor bearing mice.
Anticancer research 1999;19(1A):13-21.
1998: Wong J Y; Chu D Z; Yamauchi D; Odom-Maryon T L; Williams L E; Liu A; Esteban J M; Wu A M; Primus F J; Beatty J D; Shively J E; Raubitschek A A
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2097-104.
1998: Kaplan B E; Hefta L J; Blake R C; Swiderek K M; Shively J E
Solid-phase synthesis and characterization of carcinoembryonic antigen (CEA) domains.
The journal of peptide research : official journal of the American Peptide Society 1998;52(4):249-60.
1998: Huang J; Simpson J F; Glackin C; Riethorf L; Wagener C; Shively J E
Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells.
Anticancer research 1998;18(5A):3203-12.
1998: You Y H; Hefta L J; Yazaki P J; Wu A M; Shively J E
Expression, purification, and characterization of a two domain carcinoembryonic antigen minigene (N-A3) in pichia pastoris. The essential role of the N-domain.
Anticancer research 1998;18(5A):3193-201.
1998: Hefta L J; Neumaier M; Shively J E
Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs.
Immunotechnology : an international journal of immunological engineering 1998;4(1):49-57.
1998: Williams L E; Lewis M R; Bebb G G; Clarke K G; Odom-Maryon T L; Shively J E; Raubitschek A A
Biodistribution of 111In- and 90Y-labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: comparison of stable and chemically labile linker systems.
Bioconjugate chemistry 1998;9(1):87-93.
1998: Lewis M R; Shively J E
Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
Bioconjugate chemistry 1998;9(1):72-86.
1997: Wong J Y; Thomas G E; Yamauchi D; Williams L E; Odom-Maryon T L; Liu A; Esteban J M; Neumaier M; Dresse S; Wu A M; Primus F J; Shively J E; Raubitschek A A
Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1951-9.
1996: Grandt D; Schimiczek M; Rascher W; Feth F; Shively J; Lee T D; Davis M T; Reeve J R; Michel M C
Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors.
Regulatory peptides 1996;67(1):33-7.
1996: Chen C J; Lin T T; Shively J E
Role of interferon regulatory factor-1 in the induction of biliary glycoprotein (cell CAM-1) by interferon-gamma.
The Journal of biological chemistry 1996;271(45):28181-8.
1996: Hu S; Shively L; Raubitschek A; Sherman M; Williams L E; Wong J Y; Shively J E; Wu A M
Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.
Cancer research 1996;56(13):3055-61.
1996: Reeve J R; Eysselein V E; Rosenquist G; Zeeh J; Regner U; Ho F J; Chew P; Davis M T; Lee T D; Shively J E; Brazer S R; Liddle R A
Evidence that CCK-58 has structure that influences its biological activity.
The American journal of physiology 1996;270(5 Pt 1):G860-8.
1996: Wu A M; Chen W; Raubitschek A; Williams L E; Neumaier M; Fischer R; Hu S Z; Odom-Maryon T; Wong J Y; Shively J E
Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.
Immunotechnology : an international journal of immunological engineering 1996;2(1):21-36.
1996: Swiderek K M; Lee T D; Shively J E
Trace structural analysis of proteins.
Methods in enzymology 1996;271():68-86.
1995: Wong J Y; Williams L E; Yamauchi D M; Odom-Maryon T; Esteban J M; Neumaier M; Wu A M; Johnson D K; Primus F J; Shively J E
Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.
Cancer research 1995;55(23 Suppl):5929s-5934s.
1995: Chen C J; Li L J; Maruya A; Shively J E
In vitro and in vivo footprint analysis of the promoter of carcinoembryonic antigen in colon carcinoma cells: effects of interferon gamma treatment.
Cancer research 1995;55(17):3873-82.
1995: Bailey J M; Tu O; Issai G; Ha A; Shively J E
Automated carboxy-terminal sequence analysis of polypeptides containing C-terminal proline.
Analytical biochemistry 1995;224(2):588-96.
1994: Lewis M R; Raubitschek A; Shively J E
A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates.
Bioconjugate chemistry 1994;5(6):565-76.
1994: Chen C J; Kane R R; Primus F J; Szalai G; Hawthorne M F; Shively J E
Synthesis and characterization of oligomeric nido-carboranyl phosphate diester conjugates to antibody and antibody fragments for potential use in boron neutron capture therapy of solid tumors.
Bioconjugate chemistry 1994;5(6):557-64.
1994: Collie N L; Walsh J H; Wong H C; Shively J E; Davis M T; Lee T D; Reeve J R
Purification and sequence of rat oxyntomodulin.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(20):9362-6.
1994: Esteban J M; Felder B; Ahn C; Simpson J F; Battifora H; Shively J E
Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Cancer 1994;74(5):1575-83.
1994: Grandt D; Schimiczek M; Struk K; Shively J; Eysselein V E; Goebell H; Reeve J R
Characterization of two forms of peptide YY, PYY(1-36) and PYY(3-36), in the rabbit.
Peptides 1994;15(5):815-20.
1993: Beatty B G; Paxton R J; Hawthorne M F; Williams L E; Rickard-Dickson K J; Do T; Shively J E; Beatty J D
Pharmacokinetics of an anti-carcinoembryonic antigen monoclonal antibody conjugated to a bifunctional transition metal carborane complex (venus flytrap cluster) in tumor-bearing mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(8):1294-302.
1993: Bailey J M; Rusnak M; Shively J E
Compact protein sequencer for the C-terminal sequence analysis of peptides and proteins.
Analytical biochemistry 1993;212(2):366-74.
1993: Sauter S L; Rutherfurd S M; Wagener C; Shively J E; Hefta S A
Identification of the specific oligosaccharide sites recognized by type 1 fimbriae from Escherichia coli on nonspecific cross-reacting antigen, a CD66 cluster granulocyte glycoprotein.
The Journal of biological chemistry 1993;268(21):15510-6.
1993: Gaida F J; Pieper D; Roder U W; Shively J E; Wagener C; Neumaier M
Molecular characterization of a cloned idiotypic cascade containing a network antigenic determinant specific for the human carcinoembryonic antigen.
The Journal of biological chemistry 1993;268(19):14138-45.
1993: Mahrenholz A M; Yeh C H; Shively J E; Hefta S A
Microsequence and mass spectral analysis of nonspecific cross-reacting antigen 160, a CD15-positive neutrophil membrane glycoprotein. Demonstration of identity with biliary glycoprotein.
The Journal of biological chemistry 1993;268(18):13015-8.
1993: Stolz A; Hammond L; Lou H; Takikawa H; Ronk M; Shively J E
cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family.
The Journal of biological chemistry 1993;268(14):10448-57.
1993: Shenoy N R; Shively J E; Bailey J M
Studies in C-terminal sequencing: new reagents for the synthesis of peptidylthiohydantoins.
Journal of protein chemistry 1993;12(2):195-205.
1993: Takahashi H; Okai Y; Paxton R J; Hefta L J; Shively J E
Differential regulation of carcinoembryonic antigen and biliary glycoprotein by gamma-interferon.
Cancer research 1993;53(7):1612-9.
1992: Bailey J M; Nikfarjam F; Shenoy N R; Shively J E
Automated carboxy-terminal sequence analysis of peptides and proteins using diphenyl phosphoroisothiocyanatidate.
Protein science : a publication of the Protein Society 1992;1(12):1622-33.
1992: Hefta L J; Chen F S; Ronk M; Sauter S L; Sarin V; Oikawa S; Nakazato H; Hefta S; Shively J E
Expression of carcinoembryonic antigen and its predicted immunoglobulin-like domains in HeLa cells for epitope analysis.
Cancer research 1992;52(20):5647-55.
1992: Rutherfurd K J; Swiderek K M; Green C B; Chen S; Shively J E; Kwok S C
Purification and characterization of PSP-I and PSP-II, two major proteins from porcine seminal plasma.
Archives of biochemistry and biophysics 1992;295(2):352-9.
1992: Esteban J M; Warsi Z; Haniu M; Hall P; Shively J E; Chen S
Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation.
The American journal of pathology 1992;140(2):337-43.
1992: Yan X W; Wong J Y; Esteban J M; Kuhn J A; Beatty B G; Beatty J D; Shively J E
Effects of recombinant human gamma-interferon on carcinoembryonic antigen expression of human colon cancer cells.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;11(2):77-84.
1992: Eberlein G A; Eysselein V E; Davis M T; Lee T D; Shively J E; Grandt D; Niebel W; Williams R; Moessner J; Zeeh J
Patterns of prohormone processing. Order revealed by a new procholecystokinin-derived peptide.
The Journal of biological chemistry 1992;267(3):1517-21.
1992: Bailey J M; Shenoy N R; Ronk M; Shively J E
Automated carboxy-terminal sequence analysis of peptides.
Protein science : a publication of the Protein Society 1992;1(1):68-80.
1992: Shenoy N R; Bailey J M; Shively J E
Carboxylic acid-modified polyethylene: a novel support for the covalent immobilization of polypeptides for C-terminal sequencing.
Protein science : a publication of the Protein Society 1992;1(1):58-67.
1991: Ronk M; Shively J E; Shute E A; Blake R C
Amino acid sequence of the blue copper protein rusticyanin from Thiobacillus ferrooxidans.
Biochemistry 1991;30(39):9435-42.
1991: Rutherfurd K J; Chen S A; Shively J E
Affinity labeling of bovine adrenal 3 beta-hydroxysteroid dehydrogenase/steroid isomerase by 5'-[p-(fluorosulfonyl)benzoyl]adenosine.
Biochemistry 1991;30(33):8116-23.
1991: Rutherfurd K J; Chen S A; Shively J E
Isolation and amino acid sequence analysis of bovine adrenal 3 beta-hydroxysteroid dehydrogenase/steroid isomerase.
Biochemistry 1991;30(33):8108-16.
1991: Stolz A; Rahimi-Kiani M; Ameis D; Chan E; Ronk M; Shively J E
Molecular structure of rat hepatic 3 alpha-hydroxysteroid dehydrogenase. A member of the oxidoreductase gene family.
The Journal of biological chemistry 1991;266(23):15253-7.
1991: Esteban J M; Kuhn J A; Felder B; Wong J Y; Battifora H; Beatty J D; Wanek P M; Shively J E
Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
Cancer research 1991;51(14):3802-6.
1991: Huebner V D; Jiang R L; Lee T D; Legesse K; Walsh J H; Shively J E; Chew P; Azumi T; Reeve J R
Purification and structural characterization of progastrin-derived peptides from a human gastrinoma.
The Journal of biological chemistry 1991;266(19):12223-7.
1991: Reeve J R; Eysselein V; Eberlein G A; Chew P; Ho F J; Huebner V D; Shively J E; Lee T D; Liddle R A
Characterization of canine intestinal cholecystokinin-58 lacking its carboxyl-terminal nonapeptide. Evidence for similar post-translational processing in brain and gut.
The Journal of biological chemistry 1991;266(21):13770-6.
1991: Sauter S L; Rutherfurd S M; Wagener C; Shively J E; Hefta S A
Binding of nonspecific cross-reacting antigen, a granulocyte membrane glycoprotein, to Escherichia coli expressing type 1 fimbriae.
Infection and immunity 1991;59(7):2485-93.
1991: Mooser G; Hefta S A; Paxton R J; Shively J E; Lee T D
Isolation and sequence of an active-site peptide containing a catalytic aspartic acid from two Streptococcus sobrinus alpha-glucosyltransferases.
The Journal of biological chemistry 1991;266(14):8916-22.
1991: Paxton R J; Beatty B G; Hawthorne M F; Varadarajan A; Williams L E; Curtis F L; Knobler C B; Beatty J D; Shively J E
A transition metal complex (Venus flytrap cluster) for radioimmunodetection and radioimmunotherapy.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(8):3387-91.
1991: Eysselein V E; Reeve J R; Sternini C; Cominelli F; Davis W M; Davis M T; Lee T D; Ho F J; Ridout D; Shively J E
Structural characterization of calcitonin gene-related peptide purified from rabbit intestine.
Peptides 1991;12(2):289-95.
1991: Tressel T; McCarthy J B; Calaycay J; Lee T D; Legesse K; Shively J E; Pande H
Human plasma fibronectin. Demonstration of structural differences between the A- and B-chains in the III CS region.
The Biochemical journal 1991;274 ( Pt 3)():731-8.
1991: Reue K; Zambaux J; Wong H; Lee G; Leete T H; Ronk M; Shively J E; Sternby B; Borgström B; Ameis D
cDNA cloning of carboxyl ester lipase from human pancreas reveals a unique proline-rich repeat unit.
Journal of lipid research 1991;32(2):267-76.
1991: Calaycay J; Rusnak M; Shively J E
Microsequence analysis of peptides and proteins. IX. An improved, compact, automated instrument.
Analytical biochemistry 1991;192(1):23-31.
1990: Wong C; Hefta S A; Paxton R J; Shively J E; Mooser G
Size and subdomain architecture of the glucan-binding domain of sucrose:3-alpha-D-glucosyltransferase from Streptococcus sobrinus.
Infection and immunity 1990;58(7):2165-70.
1990: Duda R B; Wong J Y; Paxton R J; Beatty B G; Williams L E; Shively J E; Beatty J D
Localization of intraperitoneal xenografts of human colon cancer by radiolabeled anti-CEA antibodies.
Journal of surgical oncology 1990;44(2):73-7.
1990: Schrewe H; Thompson J; Bona M; Hefta L J; Maruya A; Hassauer M; Shively J E; von Kleist S; Zimmermann W
Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression.
Molecular and cellular biology 1990;10(6):2738-48.
1990: Hefta S A; Paxton R J; Shively J E
Sequence and glycosylation site identity of two distinct glycoforms of nonspecific cross-reacting antigen as demonstrated by sequence analysis and fast atom bombardment mass spectrometry.
The Journal of biological chemistry 1990;265(15):8618-26.
1990: Hefta L J; Schrewe H; Thompson J A; Oikawa S; Nakazato H; Shively J E
Expression of complementary DNA and genomic clones for carcinoembryonic antigen and nonspecific cross-reacting antigen in Chinese hamster ovary and mouse fibroblast cells and characterization of the membrane-expressed products.
Cancer research 1990;50(8):2397-403.
1990: Neumaier M; Shively L; Chen F S; Gaida F J; Ilgen C; Paxton R J; Shively J E; Riggs A D
Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
Cancer research 1990;50(7):2128-34.
1990: Bailey J M; Shively J E
Carboxy-terminal sequencing: formation and hydrolysis of C-terminal peptidylthiohydantoins.
Biochemistry 1990;29(12):3145-56.
1990: Beatty J D; Williams L E; Yamauchi D; Morton B A; Hill L R; Beatty B G; Paxton R J; Merchant B; Shively J E
Presurgical imaging with indium-labeled anti-carcinoembryonic antigen for colon cancer staging.
Cancer research 1990;50(3 Suppl):922s-926s.
1990: Williams L E; Beatty B G; Beatty J D; Wong J Y; Paxton R J; Shively J E
Estimation of monoclonal antibody-associated 90Y activity needed to achieve certain tumor radiation doses in colorectal cancer patients.
Cancer research 1990;50(3 Suppl):1029s-1030s.
1989: Wong J Y; Mivechi N F; Paxton R J; Williams L E; Beatty B G; Beatty J D; Shively J E
The effects of hyperthermia on tumor carcinoembryonic antigen expression.
International journal of radiation oncology, biology, physics 1989;17(4):803-8.
1989: Haniu M; McManus M E; Birkett D J; Lee T D; Shively J E
Structural and functional analysis of NADPH-cytochrome P-450 reductase from human liver: complete sequence of human enzyme and NADPH-binding sites.
Biochemistry 1989;28(21):8639-45.
1989: Pompon D; Liu R Y; Besman M J; Wang P L; Shively J E; Chen S
Expression of human placental aromatase in Saccharomyces cerevisiae.
Molecular endocrinology (Baltimore, Md.) 1989;3(9):1477-87.
1989: Eberlein G A; Eysselein V E; Schaeffer M; Layer P; Grandt D; Goebell H; Niebel W; Davis M; Lee T D; Shively J E
A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36).
Peptides 1989;10(4):797-803.
1989: Besman M J; Yanagibashi K; Lee T D; Kawamura M; Hall P F; Shively J E
Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(13):4897-901.
1989: Liu X F; Yuan H; Haniu M; Iyanagi T; Shively J E; Chen S A
Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase) with 5'-[p-(fluorosulfonyl)benzoyl]-adenosine.
Molecular pharmacology 1989;35(6):818-22.
1989: Wu S V; Chew P; Ho F J; Walsh J H; Wong H; Lee T D; Davis M T; Shively J E; Reeve J R
Characterization of the carboxyl terminal flanking peptide of rat progastrin.
Biochemical and biophysical research communications 1989;161(1):69-74.
1989: Beatty B G; Beatty J D; Williams L E; Paxton R J; Shively J E; O'Connor-Tressel M
Effect of specific antibody pretreatment on liver uptake of 111In-labeled anticarcinoembryonic antigen monoclonal antibody in nude mice bearing human colon cancer xenografts.
Cancer research 1989;49(6):1587-94.
1989: Wong J Y; Williams L E; Hill L R; Paxton R J; Beatty B G; Shively J E; Beatty J D
The effects of tumor mass, tumor age, and external beam radiation on tumor-specific antibody uptake.
International journal of radiation oncology, biology, physics 1989;16(3):715-20.
1989: Thompson J A; Mauch E M; Chen F S; Hinoda Y; Schrewe H; Berling B; Barnert S; von Kleist S; Shively J E; Zimmermann W
Analysis of the size of the carcinoembryonic antigen (CEA) gene family: isolation and sequencing of N-terminal domain exons.
Biochemical and biophysical research communications 1989;158(3):996-1004.
1989: Reeve J R; Cuttitta F; Vigna S R; Heubner V; Lee T D; Shively J E; Ho F J; Fedorko J; Minna J D; Walsh J H
Multiple gastrin-releasing peptide gene-associated peptides are produced by a human small cell lung cancer line.
The Journal of biological chemistry 1989;264(4):1928-32.
1989: Beatty J D; Hyams D M; Morton B A; Beatty B G; Williams L E; Yamauchi D; Merchant B; Paxton R J; Shively J E
Impact of radiolabeled antibody imaging on management of colon cancer.
American journal of surgery 1989;157(1):13-9.
1989: Chen S A; Besman M J; Shively J E; Yanagibashi K; Hall P F
Human aromatase.
Drug metabolism reviews 1989;20(2-4):511-7.
1988: Cox K L; Rosenquist G L; Iwahashi C K; Benisek W F; Reeve J R; Shively J E; Lee T; Huebner V D
Identification of serotonin from rabbit upper stomach as a stimulant of in vitro gallbladder contraction.
Biochimica et biophysica acta 1988;967(3):364-72.
1988: Turkelson C M; Solomon T E; Bussjaeger L; Turkelson J; Ronk M; Shively J E; Ho F J; Reeve J R
Chemical characterization of rat cholecystokinin-58.
Peptides 1988;9(6):1255-60.
1988: Tressel T; Shively J E; Pande H
Human placental fibronectin: demonstration of structural differences between the A and B chains in the extra domain-A region.
Archives of biochemistry and biophysics 1988;266(2):639-43.
1988: Morton B A; O'Connor-Tressel M; Beatty B G; Shively J E; Beatty J D
Artifactual CEA elevation due to human anti-mouse antibodies.
Archives of surgery (Chicago, Ill. : 1960) 1988;123(10):1242-6.
1988: Haniu M; Shively J E
Microsequence analysis of peptides and proteins. IX. Manual gas-phase microsequencing of multiple samples.
Analytical biochemistry 1988;173(2):296-306.
1988: Haniu M; Yuan H; Chen S A; Iyanagi T; Lee T D; Shively J E
Structure-function relationship of NAD(P)H:quinone reductase: characterization of NH2-terminal blocking group and essential tyrosine and lysine residues.
Biochemistry 1988;27(18):6877-83.
1988: Hinoda Y; Neumaier M; Hefta S A; Drzeniek Z; Wagener C; Shively L; Hefta L J; Shively J E; Paxton R J
Molecular cloning of a cDNA coding biliary glycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(18):6959-63.
1988: Hefta S A; Hefta L J; Lee T D; Paxton R J; Shively J E
Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: identification of the ethanolamine linkage site.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(13):4648-52.
1988: Jiang R; Huebner V D; Lee T D; Chew P; Ho F J; Shively J E; Walsh J H; Reeve J R
Isolation and characterization of rabbit gastrin.
Peptides 1988;9(4):763-9.
1988: Zimmermann W; Weber B; Ortlieb B; Rudert F; Schempp W; Fiebig H H; Shively J E; von Kleist S; Thompson J A
Chromosomal localization of the carcinoembryonic antigen gene family and differential expression in various tumors.
Cancer research 1988;48(9):2550-4.
1988: Xu Q Y; Shively J E
Microsequence analysis of peptides and proteins. VIII. Improved electroblotting of proteins onto membranes and derivatized glass-fiber sheets.
Analytical biochemistry 1988;170(1):19-30.
1988: Neumaier M; Zimmermann W; Shively L; Hinoda Y; Riggs A D; Shively J E
Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen.
The Journal of biological chemistry 1988;263(7):3202-7.
1988: Chen S A; Besman M J; Sparkes R S; Zollman S; Klisak I; Mohandas T; Hall P F; Shively J E
Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15.
DNA (Mary Ann Liebert, Inc.) 1988;7(1):27-38.
1988: Williams L E; Duda R B; Proffitt R T; Beatty B G; Beatty J D; Wong J Y; Shively J E; Paxton R J
Tumor uptake as a function of tumor mass: a mathematic model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(1):103-9.
1988: Reeve J R; Cuttitta F; Vigna S R; Shively J E; Walsh J H
Processing of mammalian preprogastrin-releasing peptide.
Annals of the New York Academy of Sciences 1988;547():21-9.
1987: Hawke D H; Lahm H W; Shively J E; Todd C W
Microsequence analysis of peptides and proteins: trimethylsilylisothiocyanate as a reagent for COOH-terminal sequence analysis.
Analytical biochemistry 1987;166(2):298-307.
1987: Beatty J D; Philben V J; Beatty B G; Williams L E; Paxton R J; Shively J E; Duda R B; Vlahos W G; Werner J L; Sheibani K
Imaging of colon carcinoma with 111-indium-labeled anti-CEA monoclonal antibodies (Indacea) prior to surgery.
Journal of surgical oncology 1987;36(2):98-104.
1987: Shively J E; Miller P; Ronk M
Microsequence analysis of peptides and proteins. VI. A continuous flow reactor for sample concentration and sequence analysis.
Analytical biochemistry 1987;163(2):517-29.
1987: Ben-Zeev O; Ben-Avram C M; Wong H; Nikazy J; Shively J E; Schotz M C
Hepatic lipase: a member of a family of structurally related lipases.
Biochimica et biophysica acta 1987;919(1):13-20.
1987: Thompson J A; Pande H; Paxton R J; Shively L; Padma A; Simmer R L; Todd C W; Riggs A D; Shively J E
Molecular cloning of a gene belonging to the carcinoembryonic antigen gene family and discussion of a domain model.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(9):2965-9.
1987: Shively J; Reeve J R; Eysselein V E; Ben-Avram C; Vigna S R; Walsh J H
CCK-5: sequence analysis of a small cholecystokinin from canine brain and intestine.
The American journal of physiology 1987;252(2 Pt 1):G272-5.
1987: Paxton R J; Mooser G; Pande H; Lee T D; Shively J E
Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(4):920-4.
1987: Pande H; Calaycay J; Lee T D; Legesse K; Shively J E; Siri A; Borsi L; Zardi L
Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain.
European journal of biochemistry / FEBS 1987;162(2):403-11.
1987: Fujita-Yamaguchi Y; Hawke D H; Shively J E; Choi S
Partial amino acid sequence analyses of human placental insulin receptor.
Protein sequences & data analysis 1987;1(1):3-6.
1986: Beatty B G; Paxton R J; Sheibani K; Duda R B; Williams L E; Shively J E; Beatty J D
Testis imaging with 111In-labeled anticarcinoembryonic antigen monoclonal antibody: identification of carcinoembryonic antigen in normal germ cells.
Cancer research 1986;46(12 Pt 1):6503-8.
1986: Beatty J D; Duda R B; Williams L E; Sheibani K; Paxton R J; Beatty B G; Philben V J; Werner J L; Shively J E; Vlahos W G
Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody.
Cancer research 1986;46(12 Pt 1):6494-502.
1986: Haniu M; Iyanagi T; Miller P; Lee T D; Shively J E
Complete amino acid sequence of NADPH-cytochrome P-450 reductase from porcine hepatic microsomes.
Biochemistry 1986;25(24):7906-11.
1986: Reeve J R; Eysselein V; Walsh J H; Ben-Avram C M; Shively J E
New molecular forms of cholecystokinin. Microsequence analysis of forms previously characterized by chromatographic methods.
The Journal of biological chemistry 1986;261(35):16392-7.
1986: Duda R B; Beatty J D; Sheibani K; Williams L E; Paxton R J; Beatty B G; Shively J E; Vlahos W G; Werner J L; Kemeny M M
Imaging of human colorectal adenocarcinoma with indium-labeled anticarcinoembryonic antigen monoclonal antibody.
Archives of surgery (Chicago, Ill. : 1960) 1986;121(11):1315-9.
1986: Iyanagi T; Haniu M; Sogawa K; Fujii-Kuriyama Y; Watanabe S; Shively J E; Anan K F
Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase.
The Journal of biological chemistry 1986;261(33):15607-14.
1986: Mogard M H; Reeve J R; Shively J E; Ben-Avram C M; Eysselein V E; Walsh J H
Isolation and characterization of a neurotensin-like decapeptide from a canine upper small intestinal extract.
Regulatory peptides 1986;14(4):313-21.
1986: Ben-Avram C M; Ben-Zeev O; Lee T D; Haaga K; Shively J E; Goers J; Pedersen M E; Reeve J R; Schotz M C
Homology of lipoprotein lipase to pancreatic lipase.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(12):4185-9.
1986: Philben V J; Jakowatz J G; Beatty B G; Vlahos W G; Paxton R J; Williams L E; Shively J E; Beatty J D
The effect of tumor CEA content and tumor size on tissue uptake of indium 111-labeled anti-CEA monoclonal antibody.
Cancer 1986;57(3):571-6.
1985: Jakowatz J G; Beatty B G; Vlahos W G; Porudominsky D; Philben V J; Williams L E; Paxton R J; Shively J E; Beatty J D
High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
Cancer research 1985;45(11 Pt 2):5700-6.
1985: Paxton R J; Jakowatz J G; Beatty J D; Beatty B G; Vlahos W G; Williams L E; Clark B R; Shively J E
High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates.
Cancer research 1985;45(11 Pt 2):5694-9.
1985: Calaycay J; Pande H; Lee T; Borsi L; Siri A; Shively J E; Zardi L
Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin.
The Journal of biological chemistry 1985;260(22):12136-41.
1985: Reeve J R; Ho F J; Walsh J H; Ben-Avram C M; Shively J E
Rapid high-yield purification of canine intestinal motilin and its complete sequence determination.
Journal of chromatography 1985;321(2):421-32.
1985: Haniu M; Iyanagi T; Miller P; Shively J E
Amino acid sequence of COOH-terminal 20K Da fragment from pig liver microsomal NADPH-cytochrome P-450 reductase.
Biochemical and biophysical research communications 1985;127(1):94-8.
1985: Pande H; Calaycay J; Hawke D; Ben-Avram C M; Shively J E
Primary structure of a glycosylated DNA-binding domain in human plasma fibronectin.
The Journal of biological chemistry 1985;260(4):2301-6.
1984: Haniu M; Iyanagi T; Legesse K; Shively J E
Structural analysis of NADPH-cytochrome P-450 reductase from porcine hepatic microsomes. Sequences of proteolytic fragments, cysteine-containing peptides, and a NADPH-protected cysteine peptide.
The Journal of biological chemistry 1984;259(22):13703-11.
1984: Orloff M S; Reeve J R; Ben-Avram C M; Shively J E; Walsh J H
Isolation and sequence analysis of human bombesin-like peptides.
Peptides 1984;5(5):865-70.
1984: Zhu B C; Fisher S F; Pande H; Calaycay J; Shively J E; Laine R A
Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin.
The Journal of biological chemistry 1984;259(6):3962-70.

Sign-in to see more